Description
USP 797, USP 795 and USP 800 have been going through revisions and will be mandated to be in place by December 1, 2019. The final versions will be in hand by April 1, 2019. The purpose of this session is to review these changes and provide a background to address the client's needs. The presentation will include an overview of USP Standards and why they are applicable to hospital pharmacy design in general, and in particular to sterile compounding, which occurs in every hospital in the country.
Learning objectives
After participating in this webinar attendees will be equipped to:
- Understand design and compliancy issues and changes associated with non-sterile compounding Labs (USP 795)
- Understand design and compliancy issues and changes associated with sterile compounding Labs (USP 797)
- Understand design and compliancy issues and changes associated with both non-sterile and sterile hazardous compounding Labs (USP 800)
- Better prepared to a compliance strategy for existing hospitals and compounding facilities
Presenter
Bob Falkum, Gates Healthcare
Earn 1 AIA LU/HSW | Tuesday, May 14, 2019 | 2–3pm ET
------------------------------
Aurelie Josserand AIA
SmithGroup
Washington DC
------------------------------